NCT00237861 Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia Status COMPLETED Phase PHASE4
NCT00237848 D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia Status COMPLETED Phase PHASE3
NCT00237809 D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia Status COMPLETED Phase PHASE3
NCT00236587 A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00236548 Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection Status COMPLETED Phase PHASE3
NCT00236457 A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE3
NCT00236379 A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00236353 Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE3
NCT00235352 Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT00235274 Effects of RG1068 (Secretin) on Information Processing in Schizophrenia Status COMPLETED Phase PHASE2
NCT00234377 Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00231894 Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00231335 Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia Status COMPLETED Phase PHASE4
NCT00230828 Patient-reported Outcomes in the Treatment of Schizophrenia Status COMPLETED Phase PHASE3
NCT00229385 Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) Status COMPLETED Phase NA